Japan's NSSK buys Sakura pharmacy chain
Japanese middle-market private equity firm NSSK has acquired 100% of Kraft, a local pharmacy chain that operates under the Sakura brand, for an undisclosed sum.
Kraft is best known for its Sakura pharmacies, which number 900 nationwide, mainly in densely populated areas such as metropolitan Tokyo and the Kansai and Tokai regions. It also offers medical and nursing...
Co-Stone leads $43m round for China biosynthesis player
Co-Stone Capital Management has led a CNY 300m (USD 43m) Series B round for Readline, a Shenzhen-based company that specialises in synthetic biology.
Australia’s Heal Partners closes debut fund on $137m
Australia’s Heal Partners, a health, education, and lifestyle-focused venture capital firm, has closed its first fund on AUD 200m (USD 137m). The target was AUD 100m.
US regulator gets access to Chinese audits
The threat of delisting that has haunted Chinese companies that trade on US exchanges appears to have receded after the US regulators announced they had gained full access to the audits of these companies for the first time.